- Home
- SCWO vs TLPH Comparison
SCWO vs TLPH Comparison
Compare SCWO & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCWO | TLPH |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 37.9M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | SCWO | TLPH |
|---|---|---|
| Price | $2.47 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 42.7K | ★ 211.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.38 |
| 52 Week High | $3.55 | $1.57 |
Technical Indicators
Market Signals| Indicator | SCWO | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 38.42 |
| Support Level | $2.33 | $0.76 |
| Resistance Level | $2.83 | $1.03 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 28.69 | 11.92 |
Price Performance
Historical ComparisonAbout SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.